The Differences in the Level of Anti-SARS-CoV-2 Antibodies after mRNA Vaccine between Convalescent and Non-Previously Infected People Disappear after the Second Dose—Study in Healthcare Workers Group in Poland

The Differences in the Level of Anti-SARS-CoV-2 Antibodies after mRNA Vaccine between Convalescent and Non-Previously Infected People Disappear after the Second Dose—Study in Healthcare Workers Group in Poland

(1) Background: In many infections, antibodies play a crucial role in controlling infection. In COVID-19, the dynamics of the immune system response to SARS-CoV-2 is not fully understood. (2) Methods: The study was conducted on 120 healthcare workers from Dr. Antoni Jurasz University Hospital No. 1...

Full description

Bibliographic Details
Main Authors: Joanna Kwiecińska-Piróg, Jana Przekwas, Zuzanna Kraszewska, Alicja Sękowska, Sylwia Brodzka, Natalia Wiktorczyk-Kapischke, Katarzyna Grudlewska-Buda, Ewa Wałecka-Zacharska, Maciej Zacharski, Aneta Mańkowska-Cyl, Eugenia Gospodarek-Komkowska, Krzysztof Skowron
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Vaccines
Subjects:
antibodies
SARS-CoV-2
vaccination
immunological response
Online Access:https://www.mdpi.com/2076-393X/9/12/1402

Internet

https://www.mdpi.com/2076-393X/9/12/1402

Similar Items